← Leaderboards
Mark W Albers
Columbia University Health Sciences
$13,654,727
Attributed
$17,339,791
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,339,791 · 12
By mechanism
R01$7,613,526 · 2
DP2$2,652,250 · 1
RF1$2,481,834 · 1
U01$1,313,892 · 1
K08$978,520 · 1
R21$911,502 · 2
Top collaborators
- Peter Karl Sorger10 shared
- Steven D Munger1 shared
- Valentina Parma1 shared
- Sean Reineke1 shared
- Kai Zhao1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Kevin Franks$7,728,520
- Alwyn Theodore Cohall$11,442,272
- Shivani Bigler$133,696
- David R Kaufman$1,552,821
- S. Abid Hussaini$8,143,102
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposNeuronsS DiseasePhenotypeBrainSignal TransductionLeadGene ExpressionInflammatoryMemberEvaluationPathologyPathologicSynapsesPreventCell TypePathway InteractionsGenomeCommunitiesClinical TrialsCellsPharmaceutical PreparationsEventDisease Progression
Grant awards (28)
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD$804,740
R01 · FY2025 · AG · contact PI
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias$751,103
R01 · FY2025 · AG · contact PI
Digital Accessible Remote Olfactory Mediated Health Assessments for Lewy Body Disease$493,964
R41 · FY2025 · AG
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias$113,250
R01 · FY2025 · AG · contact PI
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias$79,380
R01 · FY2025 · AG · contact PI
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias$973,322
R01 · FY2024 · AG · contact PI
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias$1,054,706
R01 · FY2023 · AG · contact PI
Towards Universal Chemosensory Testing$40,000
R13 · FY2023 · DC
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD$2,481,834
RF1 · FY2022 · AG · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease$733,145
R01 · FY2022 · AG · contact PI
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2$436,605
U01 · FY2022 · DC · contact PI
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2$877,287
U01 · FY2021 · DC · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease$748,092
R01 · FY2021 · AG · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease$759,291
R01 · FY2020 · AG · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease$768,451
R01 · FY2019 · AG · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease$828,046
R01 · FY2018 · AG · contact PI
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD$18,879
R41 · FY2018 · AG · contact PI
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimer's Disease$835,424
R56 · FY2017 · AG · contact PI
Propagation of Neurodegeneration by Innate Immune Pattern Recognition Receptors In Vivo$208,384
R21 · FY2016 · NS · contact PI
Propagation of Neurodegeneration by Innate Immune Pattern Recognition Receptors In Vivo$248,508
R21 · FY2015 · NS · contact PI
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting$205,619
R21 · FY2014 · NS · contact PI
Physiologic Mechanisms of Action of APP and APLP2 in Axon Targeting$248,991
R21 · FY2013 · NS · contact PI
The Olfactory Neural Circuit as a systems Level Model of Neurodegenerative Diseas$2,652,250
DP2 · FY2009 · OD · contact PI
Mapping Molecular and Cellular Responses to Odorants$199,004
K08 · FY2005 · DC
Mapping Molecular and Cellular Responses to Odorants$198,084
K08 · FY2004 · DC
Mapping Molecular and Cellular Responses to Odorants$197,190
K08 · FY2003 · DC
Mapping Molecular and Cellular Responses to Odorants$194,162
K08 · FY2002 · DC
Mapping Molecular and Cellular Responses to Odorants$190,080
K08 · FY2001 · DC